---

 

2022

29.11.2022  Half-Year Report 2022/23: Rising Energy and Raw Material Prices Put Pressure on EBITDA Margin

21.10.2022  Over 30 Percent Net Sales Increase in First Business Half-Year

13.10.2022  Gas and Electricity Saving Precaution Measures Against Shortages

01.07.2022  Shareholders Approve all Proposals of the Board of Directors

31.05.2022  Annual Report 2021/22: DOTTIKON ES Continues to Grow; Rising Raw Material Costs Affect Margins

 

2021

26.11.2021  Half-Year Report 2021/22: Growth at Consistent Profitability

02.07.2021  Shareholders Approve all Proposals of the Board of Directors

28.05.2021  Annual Report 2020/21: Further Growth, Expansion is Progressing

10.03.2021  CHF 200 Million Proceeds for Growth from Capital Increase

08.03.2021  Capital Increase – Books Are Fully Covered

05.03.2021  Capital Increase – Already Full Exercise of Rights by Core Shareholders

26.02.2021  Terms for Capital Increase

18.02.2021  Capital Increase to Finance Investments for Growth

 

2020

27.11.2020  Shareholders Approve all Proposals of the Board of Directors

27.11.2020  Half-Year Report 2020/21: Growth, Higher Profitability and Construction of New Production Plant

20.10.2020  DOTTIKON ES Proposes Share Split and Authorized Capital Increase for Growth

03.07.2020  Shareholders Approve all Proposals of the Board of Directors

29.05.2020  Annual Report 2019/20: Higher Sales and Net Income – Investments in Further Growth

07.02.2020  DOTTIKON ES Expects Growth Momentum and Appoints Dr. Bernhard Urwyler as Advisor

02.01.2020  Handover of Production Senior Management Position

 

2019

12.12.2019  Markus Blocher Reorganizes Equity Interest Structure, Increases Total Stake

29.11.2019  Half-Year Report 2019/20: Strong Growth and Significant Net Income Increase

05.07.2019  Handover of Processes & Technologies Senior Management Position

05.07.2019  Shareholders Approve all Proposals of the Board of Directors

28.05.2019  Annual Report 2018/19: Stronger Second Half-Year, Full Business Year Below Previous Year

 

2018

27.11.2018  Half-Year Report 2018/19: Lower Sales and Net Income

22.10.2018  Considerably Lower Net Sales and Net Income

19.07.2018  Change of Regulatory Standard to Swiss Reporting Standard

06.07.2018  Shareholders Approve all Proposals of the Board of Directors

31.05.2018  Annual Report 2017/18: Higher Investments, Net Sales, and Net Income

 

2017

28.11.2017  Half-Year Report 2017/18: Higher Sales, Growth Impacts Margins

11.10.2017  Change to Swiss GAAP FER as of April 1, 2018

07.07.2017  Shareholders Approve all Proposals of the Board of Directors

07.07.2017  Plans to Change from IFRS to Swiss GAAP FER

30.05.2017  Annual Report 2016/17: Strong Sales and Income Growth and Higher Profitability

21.04.2017  Alignment – Extraordinary Effects and Unchanged Outlook

28.03.2017  Appointment of Additional Senior Management Member

 

2016

25.11.2016  Half-Year Report 2016/17: Strong Organic Growth in Sales and Profitability

26.10.2016  Strong Organic Sales Growth and Profit Hike

04.10.2016  Reinforced Collaboration with Bachem on Amino Acids

01.07.2016  Shareholders Approve all Proposals of the Board of Directors

31.05.2016  Annual Report 2015/16: Tenfold Increase in Net Income

15.04.2016  Strong Organic Sales Growth in Business Year 2015/16

11.03.2016  Major Investments and Increase in Headcount in Switzerland

04.03.2016  Profit Warning/Profit Hike

 

2015

27.11.2015  Half-Year Report 2015/16: Further Increase in Net Sales and Net Income

03.07.2015  Shareholders Approve all Proposals of the Board of Directors

29.05.2015  Annual Report 2014/15: Higher Sales and Net Income

21.04.2015  Higher Sales and Net Income

09.01.2015  Sarasin Investmentfonds AG Falls Below 3% Threshold

 

2014

19.12.2014  Change in Senior Management

19.12.2014  Increase in Strategic SYSTAG Share to 47%

28.11.2014  Half-Year Report 2014/15: Less Loss, Increase in Development Capacities and SYSTAG Share

05.11.2014  Plan to Increase Strategic SYSTAG Share

23.09.2014  Reduction of Share Capital by CHF 4.90 per Registered Share

04.07.2014  Shareholders Approve all Proposals of the Board of Directors

30.05.2014  Annual Report 2013/14: Increase in Sales and Operating Profit

06.02.2014  Handover of Senior Management Position

 

2013

29.11.2013  Half-Year Report 2013/14: Increase in Net Sales and Lower Loss

05.07.2013  Shareholders Approve all Proposals of the Board of Directors

29.05.2013  Annual Report 2012/13: Sales Increase and Again Loss, but Broader Basis

 

2012

30.11.2012  Half-Year Report 2013/14: Increase in Net Sales and Lower Loss

16.11.2012  Delays Affect Result

17.09.2012  Expansion of Process Development and Catalysis Capacity

26.07.2012  Acquisition Talks about Solvias Business Unit

06.07.2012  Shareholders Approve all Proposals of the Board of Directors

29.05.2012  Annual Report 2011/12: Slight Sales Increase and Smaller Loss

20.04.2012  Slight Sales Increase and Smaller Loss

30.03.2012  Foundation of US Corporation

17.01.2012  Nomination for Election of Dr. Thomas Früh to the Board of Directors

 

2011

29.11.2011  Half-Year Report 2011/12: Again Lower Sales and Loss

19.08.2011  Termination of Short Hours in All Plant Sections

01.07.2011  Shareholders Approve all Proposals of the Board of Directors

31.05.2011  Annual Report 2010/11: Lower Sales and Loss

 

2010

31.12.2010  Sarasin Investmentfonds AG Holds 3% of DOTTIKON ES HOLDING AG

26.11.2010  Half-Year Report 2010/11: Lower Sales and Loss

04.11.2010  Expectation of Lower Sales and Loss

02.07.2010  Shareholders Approve all Proposals of the Board of Directors

28.05.2010  Annual Report 2009/10: Lower Sales and Net Income

26.04.2010  Appointment of New Member of the Senior Management

25.03.2010  Markus Blocher Holds 66.69% of DOTTIKON ES HOLDING AG

15.02.2010  Intention to Introduce Short Hours in Some Plant Sections

 

2009

27.11.2009  Half-Year Report 2009/10: Lower Sales and Net Income, More Investments

10.08.2009  Strengthening of Focus on Processes and Technologies

02.07.2009  Shareholders Approve all Proposals of the Board of Directors

29.05.2009  Annual Report 2008/09: Investments, Increase in Net Sales and Net Income

 

2008

05.12.2008  Markus Blocher Holds 66.07% of DOTTIKON ES HOLDING AG

28.11.2008  Half-Year Report 2008/09: Increased Net Sales and Net Income

04.07.2008  Shareholders Approve all Proposals of the Board of Directors

30.05.2008  Annual Report 2007/08: Investments, Increase in Net Sales and Net Income

30.04.2008  Appointment of Head of Legal & Human Resources

 

2007

24.12.2007  UBS Fund Management (Switzerland) AG holds 3.65% of DOTTIKON ES HOLDING AG

29.11.2007  Half-Year Report 2007/08: Preparatory Efforts for Upcoming Growth

06.07.2007  Shareholders Approve all Proposals of the Board of Directors

31.05.2007  Annual Report 2006/07: Increase in Net Sales and Operating Results

 

2006

30.11.2006  Half-Year Report 2006/07: Increased Net Sales and Profit

18.08.2006  Shareholders Approve all Proposals of the Board of Directors

12.06.2006  Annual Report 2005/06: More than 40% Operating Profit Increase

11.05.2006  Appointment of New CFO

 

2005

08.12.2005  Acquisition of 33.9% of SYSTAG, System Technik AG

23.11.2005  Markus Blocher Holds Over 55.6% of DOTTIKON ES HOLDING AG

23.11.2005  EMESTA Holding AG Holds Less than 5.00% of DOTTIKON ES HOLDING AG

22.11.2005  First Half-Year Report 2005/06: Higher Net Sales - Lower Net Income

27.06.2005  Markus Blocher Holds 5.01% of DOTTIKON ES HOLDING AG

08.06.2005  Change of Business Year to April 1 to March 31

21.04.2005  Dr. Peter Grogg Holds 5.03% of DOTTIKON ES HOLDING AG

21.04.2005  Miriam Blocher Holds 5.11% of DOTTIKON ES HOLDING AG

12.04.2005  Higher Net Sales Revenue in First Quarter 2005

04.04.2005  EMESTA Holding AG Holds 50.09% of DOTTIKON ES HOLDING AG

31.03.2005  First Trading Day, Review

 

---

---

---